First Time Loading...

Resmed Inc
NYSE:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
NYSE:RMD
Watchlist
Price: 214.9 USD -0.05%
Updated: May 2, 2024

Resmed Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Resmed Inc
Cash from Financing Activities Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Resmed Inc
NYSE:RMD
Cash from Financing Activities
-$914.6m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
-13%
Becton Dickinson and Co
NYSE:BDX
Cash from Financing Activities
-$2.3B
CAGR 3-Years
-144%
CAGR 5-Years
4%
CAGR 10-Years
-10%
Boston Scientific Corp
NYSE:BSX
Cash from Financing Activities
$5m
CAGR 3-Years
N/A
CAGR 5-Years
-73%
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Cash from Financing Activities
-$1.5B
CAGR 3-Years
-73%
CAGR 5-Years
-15%
CAGR 10-Years
-25%
Abbott Laboratories
NYSE:ABT
Cash from Financing Activities
-$7.1B
CAGR 3-Years
-33%
CAGR 5-Years
-7%
CAGR 10-Years
-9%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash from Financing Activities
$46.9m
CAGR 3-Years
N/A
CAGR 5-Years
-13%
CAGR 10-Years
N/A

See Also

What is Resmed Inc's Cash from Financing Activities?
Cash from Financing Activities
-914.6m USD

Based on the financial report for Mar 31, 2024, Resmed Inc's Cash from Financing Activities amounts to -914.6m USD.

What is Resmed Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-13%

The average annual Cash from Financing Activities growth rates for Resmed Inc have been -1% over the past three years , and -13% over the past ten years .